For help on how to get the results you want, see our search tips.
29 results
Keyword Remove keyword
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Salmeterol and Fluticasone Propionate
Salmeterol and fluticasone, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/01/2003, EC decision date: 21/05/2003, Last updated: 31/07/2003 -
List item
Referral: Norditropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, Last updated: 29/08/2003 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone / ethinylestradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, -
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: Position provided by CMDh, opinion/position date: 18/09/2013, -
List item
Referral: Hydroxyethyl starch solutions for infusion
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, -
List item
Referral: MultiHance
gadobenic acid, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2000, EC decision date: 15/09/2000, -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, -
List item
Referral: Prozac
Fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, -
List item
Referral: Lisinopril Biochemie
Lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, -
List item
Referral: Sortis
atorvastatin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/03/2006, EC decision date: 22/05/2006, -
List item
Referral: Methadone medicinal products for oral use containing povidone
methadone, Article 107i procedures
Status: Position provided by CMDh, opinion/position date: 23/07/2014, Last updated: 04/08/2014 -
List item
Referral: Hydroxyethyl starch (HES) containing medicinal products
hydroxyethyl starch (HES), Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/10/2017, EC decision date: 17/07/2018, Last updated: 27/07/2018 -
List item
Referral: Flupirtine-containing medicines
flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid / valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, -
List item
Referral: Cardiostad
lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, -
List item
Referral: Arcoxia
etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, -
List item
Referral: Bifril, Teoula, Zofepril, Zopranol
zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, -
List item
Referral: Yaz 24+4
ethinylestradiol / drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, -
List item
Referral: Genotropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, EC decision date: 26/06/2003, -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, -
List item
Referral: Actira
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, -
List item
Referral: Avelox
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, -
List item
Referral: Zofenil, Zopranol, Bifril
zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, -
List item
Referral: Extraneal
icodextrin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 20/01/2010, -
List item
Referral: Octegra
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008,